Back to Journals » Journal of Pain Research » Cannabis as pain medicine - the dark vs. the light side of a newly discovered treatment
Journal of Pain Research
ISSN: 1178-7090
- View all (3121)
- Volume 17, 2024 (198)
- Volume 16, 2023 (350)
- Volume 15, 2022 (331)
- Volume 14, 2021 (356)
- Volume 13, 2020 (359)
- Volume 12, 2019 (330)
- Volume 11, 2018 (336)
- Volume 10, 2017 (309)
- Volume 9, 2016 (140)
- Volume 8, 2015 (93)
- Volume 7, 2014 (76)
- Volume 6, 2013 (88)
- Volume 5, 2012 (63)
- Volume 4, 2011 (44)
- Volume 3, 2010 (26)
- Volume 2, 2009 (15)
- Volume 1, 2008 (7)
Journal Articles:
- Complex Regional Pain Syndrome (8)
- Dysmenorrhea: Therapy and Mechanism (5)
- Orofacial Pain: A new US Dental Specialty. Where are we now? (3)
- Pain in Space: a Journey of Discovery (2)
- Cancer Pain (8)
- The Future of Pain Medicine: Emerging Technologies, Treatments, and Education (1)
- Childbirth and Postpartum Pain: The Importance of Maternal Pain Control Beyond the Birth Experience (9)
- Cannabis as pain medicine - the dark vs. the light side of a newly discovered treatment (1)
- Methylnaltrexone for Opioid-Induced Constipation (2)
- Tapentadol for moderate to severe acute pain in children and adolescents (11)
- Inhaled methoxyflurane for the treatment of acute trauma pain (4)
- Tapentadol: just another opioid or an innovative strong analgesic? (8)
- From acute to chronic pain: bench to bedside findings from consortium of SIMPAR young researchers (4)
- Oral Methylnaltrexone in the treatment of patients with opioid-induced constipation and noncancer pain (2)
Cannabis as pain medicine - the dark vs. the light side of a newly discovered treatment
With the increasingly frequent, widespread and ultimately also earlier use of medical cannabis as pharmacotherapy for pain, the need for high-quality medical-scientific information is growing - especially in order to be able to provide well-founded answers to the unanswered questions of many health professionals and patients regarding the real additional benefit of cannabis in pain medicine, the differential effects of THC and CBD as the most prominent components cannabis, the peculiar role of other constituents of the cannabis plant(s) (such as terpenes and flavonoids) and the relevance of the undesirable cognitive and psychiatric side effects known from recreational use also for the use in patients with chronic pain. This Collection provides an overview of the current state of scientific knowledge around cannabis as a pain medicine.
Perceptions and Preoccupations of Patients and Physicians Regarding Use of Medical Cannabis as an Intervention Against Chronic Musculoskeletal Pain: Results from a Qualitative Study
Poisblaud L, Kröger E, Jauvin N, Pelletier-Jacob J, Bélanger RE, Foldes-Busque G, Aubin M, Pluye P, Guillaumie L, Amiri M, Dagenais P, Dionne CE
Journal of Pain Research 2023, 16:3463-3475
Published Date: 18 October 2023